Ultromics is setting new standards for world-class cardiovascular diagnostic tools, together with clinicians and powered by artificial intelligence.
They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence. To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
B2B
26 to 50
Series A
$26,024,354
Scaling Up
2017
Managed Health Care
Health Care Facilities & Hospitals
N/A
N/A
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Software
Sep 2020
- Ultromics Awarded NHSX Grant to Implement EchoGo in The NHS
May 2020
- Mayo Clinic Collaborates with Ultromics to Optimize The Impact of AI Tools On Care Pathways
Clinical Applications Lead/Ultrasound AI
Remote, Remote
Echocardiographer
Remote, Remote
Software Test Engineer
Oxford , England
Statistician
Oxford , England
Customer Experience Manager - IT
Oxford , England
AI/ML Professionals
Want to work at Ultromics?
We can introduce you to the right person at Ultromics
4
1
$33M
Company was founded 2017 and it took almost 4 years (Aug 2021) to raise first external round
Investors
Interested in researching Ultromics?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Ultromics
Potential Customers
Interested in what they do or partnership?
Learn more about how they work